San Francisco – November 12, 2026 – Cooley advised the initial purchasers of Guardant Health (Nasdaq: GH), a leading precision oncology company, in connection with its offering of $500 million aggregate principal amount of 0% convertible senior notes due 2032 in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Guardant Health also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $50 million aggregate principal amount of notes.

Partners Denny Won, Kristin VanderPas, David Peinsipp, Charlie Kim, Mischi a Marca and Jason Savich led the Cooley team advising the initial purchasers. Timothy Nguyen, Shimeng Cheng, Jennifer Shanley, Randy Sabett, Natasha Leskovsek, Eileen Marshall, Carol Laherty, Madhuri Roy, Karen Tsai and Orion Armon provided invaluable support.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.

Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.